Pharmacogenomics aims to develop rational means to optimize drug therapy with respect to the patient’s genotype, ensuring maximum drug efficiency with minimal adverse effects. A deeper understanding of different groups and populations improves pharmacovigilance, clinical trials, and the real-world therapeutic efficiency of drugs.
Explore related content and topics
resource
PRA Health Sciences To Report Fourth Quarter 2014 Earnings
PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its fourth quarter and year end 2014 results after the market closes on Wednesday, February 18,…
Fact Sheet
Risk Management Services
PRA Health Sciences (PRA) experts have significant experience providing end-to-end risk management services. Our integrated global teams identify…
Blog
Pharmacovigilance and its Place in the Industry
Pharmacovigilance ensures patients can trust the people handling their healthcare. Learn more about the importance of patient safety and what we’re…